Zdrowie i gospodarka · 15/10/1996
FDA Proposes to Ban Over-the-Counter Colloidal Silver Products
The US Food and Drug Administration (FDA) is proposing to classify all over-the-counter (OTC) medications containing colloidal silver ingredients or silver salts as misbranded, citing a lack of scientific evidence supporting their use for various serious diseases.
Source: Federal Register — Food and Drug AdministrationOpen original release →